Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.
In a study published in Science Immunology, researchers have shown that natural killer cells (NK cells), which are a fundamental part of the body’s immune system, can recognise many different viruses including global pathogens such as Zika, dengue and Hepatitis C viruses, through a single receptor called KIR2DS2.
Lead researcher Salim Khakoo, Professor of Hepatology, said the findings are very exciting and could change the way viruses are targeted by vaccines but warned that the research is still at an early stage, and animal studies/clinical trials will be needed to test the findings.
Vaccines work by stimulating the immune response to the coat of proteins on the virus enabling the body to fight off the virus and recognise it in the future. However, the viruses are able to change their coat proteins, helping the virus to evade the antibodies, meaning some viruses can be very hard to vaccinate against.
The Southampton team have shown that this NK cell receptor is able to target a non-variable part of the virus called the NS3 helicase protein, which is essential in making the virus work properly. Unlike other proteins, the NS3 helicase protein does not change, which allows the immune system to grab hold of it and let the NK cells deal with the threat.
Professor Khakoo said: “The NS3 helicase protein could be the key in unlocking the defence of lethal viruses that affect so many people around the world. It is very exciting to discover that other viruses similar to Hepatitis C, such as Zika virus, dengue virus, yellow fever virus, Japanese encephalitis virus and in fact all flaviviruses, contain a region within their NS3 helicase proteins that is recognised by exactly the same KIR2DS2 receptor. We believe that by targeting this NS3 helicase region, we could make a new type of vaccine based upon natural killer cells, which can be used to help protect people from these infections.”
The study, which was funded by the Wellcome Trust and the Medical Research Council, analysed DNA from more than 300 patients exposed to the Hepatitis C virus, which showed that the KIR2DS2 receptor was associated with successfully clearing the virus. The team then identified that the immune system targeted the NS3 helicase protein of this using the receptor and found that it prevented the virus multiplying.
They went on to demonstrate that this same mechanism icould be important for many different viruses for example the Zika and dengue viruses, which also contain a region within their NS3 helicase protein that is recognised by the KIR2DS2 receptor.
The researchers now need to determine whether these KIR2DS2+ NK cells are protective during acute flaviviral infections, and are hoping to develop a vaccine that targets natural killer cells. They believe that a similar process could be used to target cancer.
Professor Khakoo added: “Cancer treatments that use the body’s own immune system are becoming more common. Our findings present a completely new strategy for virus therapeutics which could be easily translated into the field of cancer. The next few years are going to be very exciting in this field.”
The Latest on: Vaccine for viruses
[google_news title=”” keyword=”vaccine for viruses” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Pakistan withdraws Covid-19 vaccination certificate requirement for Haj visitorson December 4, 2023 at 3:48 pm
Taking to X, the ministry posted, "The condition for corona[virus] vaccine has been abolished. Haj pilgrims do not need to submit their coronavirus [vaccination] certificates."The Pakistan-based news ...
- Got your flu and COVID shots? Lexington health department reports cases are on the riseon December 4, 2023 at 12:54 pm
The area is now up to 227 lab-confirmed influenza cases, and about 87% of those occurred in people who had not gotten their seasonal flu shot. Additionally, last week was the third week in a row ...
- Complications from flu largely preventable with annual flu vaccineon December 4, 2023 at 8:04 am
During National Influenza Vaccination Week (December 4-8, 2023), leading public health organizations are encouraging everyone to get a flu shot if they have not already done so.
- HSE issues urgent Christmas winter virus warning for parents as cases set to skyrocketon December 4, 2023 at 12:12 am
THE HSE has issued an urgent warning to Irish parents as winter virus cases are set to skyrocket over Christmas. The health executive is urging all children and teens to get the free flu ...
- Free nasal spray flu vaccine programme extended to children aged between 13 and 17on December 3, 2023 at 10:00 pm
FREE FLU VACCINES have been extended to include children aged between 13 and 17. The change takes effect from today and means all children aged 2 to 17 are now eligible for the flu vaccine as part of ...
- Flu vaccine extended to teenagers aged 13 - 17 as parents urged to have children vaccinated before Christmason December 3, 2023 at 4:01 pm
Parents of children and young adults are being urged to get them the nasal flu vaccine before Christmas amid warnings that the circulation of the virus is increasing and younger people are twice as ...
- COVID-19 and flu set to peak over holiday season in Ontario; Moore urges vaccinationson December 3, 2023 at 4:00 pm
Flu activity is also on the rise ... Health Canada has approved an RSV vaccine for people aged 60 and older, but it is only available free of charge to people in that age group living in long-term ...
- Six More Lives Claimed from Respiratory Viruses in Newfoundland and Labradoron December 2, 2023 at 3:31 am
Respiratory viruses have claimed six more lives in Newfoundland and Labrador. The province’s new respiratory virus dashboard was updated earlier today, covering the reporting period of November 19th ...
- Here are the respiratory illness vaccines available to seniors in N.S. this seasonon December 2, 2023 at 2:00 am
The high-dose influenza, COVID-19 and pneumococcal vaccines are publicly funded. But people need to pay for the new respiratory syncytial virus (RSV) vaccine for people aged 60.
- Major boost as nasal spray flu vaccine extended to children over 13 for FREE – here’s everything you need to knowon December 1, 2023 at 12:58 pm
A MAJOR boost has been made as the nasal spray flu vaccine will be extended to children aged 13-17 in Ireland – and it’s completely free. The nasal vaccine will be made available to ...
via Google News and Bing News